Work

A phase I/II trial of sorafenib (S) with bevacizumab (B) in metastatic renal cell cancer (mRCC) patients (Pts)

Year: 2006

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2006.24.18_suppl.3031

Authors: J. A. Sosman, K. Flaherty, M. B. Atkins, I. Puzanov, D. F. McDermott, W. Vermeulen, K. Harlacker, A. Hsu, M. Rothenberg

Institutions: Beth Israel Deaconess Medical Center, University of Pennsylvania, Vanderbilt University Medical Center

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2262674549

Cites:

Cited by: 46

Related to: 10